These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24533717)

  • 21. Pharmacogenetics: The right drug for you.
    Drew L
    Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
    [No Abstract]   [Full Text] [Related]  

  • 22. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics.
    Wolf CR; Smith G
    Br Med Bull; 1999; 55(2):366-86. PubMed ID: 10723863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 pharmacogenetics in African populations: implications for public health.
    Dandara C; Swart M; Mpeta B; Wonkam A; Masimirembwa C
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):769-85. PubMed ID: 24588448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying drugs needing pharmacogenetic monitoring in a Korean hospital.
    Kim YM; Yoo SH; Kang RY; Kim MJ; Bae YY; Lee YK; Jeon SJ; Chon KJ; Shin SM; Kim SG; Park KH; Son IJ
    Am J Health Syst Pharm; 2007 Jan; 64(2):166-75. PubMed ID: 17215467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence.
    Ravyn D; Ravyn V; Lowney R; Nasrallah HA
    Schizophr Res; 2013 Sep; 149(1-3):1-14. PubMed ID: 23870808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of clinical pharmacogenetics Studies in African populations.
    Radouani F; Zass L; Hamdi Y; Rocha JD; Sallam R; Abdelhak S; Ahmed S; Azzouzi M; Benamri I; Benkahla A; Bouhaouala-Zahar B; Chaouch M; Jmel H; Kefi R; Ksouri A; Kumuthini J; Masilela P; Masimirembwa C; Othman H; Panji S; Romdhane L; Samtal C; Sibira R; Ghedira K; Fadlelmola F; Kassim SK; Mulder N
    Per Med; 2020 Mar; 17(2):155-170. PubMed ID: 32125935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
    Pratt VM; Everts RE; Aggarwal P; Beyer BN; Broeckel U; Epstein-Baak R; Hujsak P; Kornreich R; Liao J; Lorier R; Scott SA; Smith CH; Toji LH; Turner A; Kalman LV
    J Mol Diagn; 2016 Jan; 18(1):109-23. PubMed ID: 26621101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa.
    Baker JL; Shriner D; Bentley AR; Rotimi CN
    Pharmacogenomics J; 2017 Mar; 17(2):112-120. PubMed ID: 27779243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of the pharmacogenetics of HIV therapy.
    Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nácher I; Soriano V
    Pharmacogenomics J; 2006; 6(4):234-45. PubMed ID: 16462814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation.
    Martis S; Mei H; Vijzelaar R; Edelmann L; Desnick RJ; Scott SA
    Pharmacogenomics J; 2013 Dec; 13(6):558-66. PubMed ID: 23164804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacogenetics: towards personalized medicine].
    Gurwitz D; Rehavi M
    Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetic testing in psychiatry: a review of features and clinical realities.
    de Leon J; Arranz MJ; Ruaño G
    Clin Lab Med; 2008 Dec; 28(4):599-617. PubMed ID: 19059065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
    Ingelman-Sundberg M
    Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacogenetics. Tailored therapy in medicine -- opportunities and challenges].
    Scharplatz M; Puhan M; Steurer J; Bachmann LM
    Praxis (Bern 1994); 2004 Mar; 93(10):359-65. PubMed ID: 15052854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Will pharmacogenomics guide clinical practice?
    Licinio J; Alvarado I; Wong ML
    Pharmacogenomics J; 2002; 2(2):71. PubMed ID: 12049176
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
    Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
    OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of mood disorders: what clinicians need to know.
    Laje G
    CNS Spectr; 2013 Oct; 18(5):272-84. PubMed ID: 24050155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics in Ghana: reviewing the evidence.
    Kudzi W; Adjei GO; Ofori-Adjei D; Dodoo AN
    Ghana Med J; 2011 Jun; 45(2):73-80. PubMed ID: 21857725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in pharmacogenetics and pharmacogenomics.
    Vesell ES
    J Clin Pharmacol; 2000 Sep; 40(9):930-8. PubMed ID: 10975065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.